ZHX2 and hepatocellular carcinoma: Vice versa, increasing LPL expression in HCC cells could reverse ZHX2-mediated cell proliferation inhibition, tumor growth in a xenograft mouse model, lipid metabolism, and tumor formation in mouse liver.